0001209191-18-028123.txt : 20180504 0001209191-18-028123.hdr.sgml : 20180504 20180504163616 ACCESSION NUMBER: 0001209191-18-028123 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180503 FILED AS OF DATE: 20180504 DATE AS OF CHANGE: 20180504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kwon Paul CENTRAL INDEX KEY: 0001727717 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 18808461 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Menlo Therapeutics Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-486-1416 MAIL ADDRESS: STREET 1: 200 CARDINAL WAY, 2ND FLOOR CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Menlo Therapeutics, Inc. DATE OF NAME CHANGE: 20170728 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-03 0 0001566044 Menlo Therapeutics Inc. MNLO 0001727717 Kwon Paul 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 0 1 0 0 Chief Medical Officer Stock Option 8.49 2018-05-03 4 A 0 64000 0.00 A 2028-05-02 Common Stock 64000 252512 D The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly. /s/ Stephen Thau, as attorney-in-fact 2018-05-04